17 results
S-3
EX-4.7
LIXT
Lixte Biotechnology Holdings Inc
Shelf registration
23 Apr 24
1:46pm
8-K
EX-4.2
LIXT
Lixte Biotechnology Holdings Inc
20 Jul 23
Entry into a Material Definitive Agreement
11:45am
8-K
EX-4.3
LIXT
Lixte Biotechnology Holdings Inc
20 Jul 23
Entry into a Material Definitive Agreement
11:45am
8-K
EX-4.1
LIXT
Lixte Biotechnology Holdings Inc
20 Jul 23
Entry into a Material Definitive Agreement
11:45am
8-K
EX-4.1
LIXT
Lixte Biotechnology Holdings Inc
15 Apr 22
LIXTE Biotechnology Announces $5.8 Million Registered Direct Offering Priced At-The-Market
12:00am
8-K
EX-4.1
yyx5hy4kn0r6atpa
2 Mar 21
VI.Lixte Biotechnology Announces $4.19 Million Registered Direct Offering
4:55pm
S-3
EX-4.7
w7nky9qp7rgq4xt167t4
26 Jan 21
Shelf registration
12:03pm
8-K
EX-4.1
ors6za4diasr 9o
27 Nov 20
Lixte Biotechnology Holdings, Inc. Announces Pricing of $5,700,000 Public Offering; Uplisting to Nasdaq Capital Market and Reverse Stock Split
4:43pm
8-K
EX-4
rpwnwki6r
27 Nov 20
Lixte Biotechnology Holdings, Inc. Announces Pricing of $5,700,000 Public Offering; Uplisting to Nasdaq Capital Market and Reverse Stock Split
4:43pm
8-K
EX-4.1
kanw49rbtod3px
5 Dec 18
Unregistered Sales of Equity Securities
12:00am
8-K
EX-4.02
tg99w1rvgha
18 Sep 15
Lixte Biotechnology Holdings, Inc. Engages Biopharmaworks LLC to Enhance Development of Its Pipeline of Novel Compounds
12:00am
8-K
EX-4.01
u743 aebamwiyvxqp
18 Sep 15
Lixte Biotechnology Holdings, Inc. Engages Biopharmaworks LLC to Enhance Development of Its Pipeline of Novel Compounds
12:00am
8-K
EX-4.01
vspuojur2x
18 Mar 15
Lixte Completes Private Placement of Convertible Preferred Stock
12:00am
- Prev
- 1
- Next